Record Information |
---|
Version | 1.0 |
---|
Created at | 2021-06-21 00:23:33 UTC |
---|
Updated at | 2021-06-30 00:18:08 UTC |
---|
NP-MRD ID | NP0042821 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | tuberostemospiroline |
---|
Provided By | JEOL Database |
---|
Description | Tuberostemospiroline belongs to the class of organic compounds known as tuberostemospironine-type alkaloids. These are alkaloids with a structure that is characterized by a 2H-spiro[furan-2,9A[9H]pyrrolo[1,2-a]azepin]-\n5-one nucleus which displays a spiro gamma-lactone at C-9 of the basic ring. tuberostemospiroline is found in Stemona tuberosa. It was first documented in 2013 (PMID: 24088701). Based on a literature review a small amount of articles have been published on Tuberostemospiroline (PMID: 33848039) (PMID: 25145296). |
---|
Structure | [H]C([H])([H])[C@@]1([H])C(=O)O[C@]2(C1([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N1C(=O)C([H])([H])C([H])([H])[C@@]21[H] InChI=1S/C13H19NO3/c1-9-8-13(17-12(9)16)6-2-3-7-14-10(13)4-5-11(14)15/h9-10H,2-8H2,1H3/t9-,10+,13+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C13H19NO3 |
---|
Average Mass | 237.2990 Da |
---|
Monoisotopic Mass | 237.13649 Da |
---|
IUPAC Name | (2S,4R,9'aS)-4-methyl-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepine]-3',5-dione |
---|
Traditional Name | (2S,4R,9'aS)-4-methyl-hexahydro-1'H-spiro[oxolane-2,9'-pyrrolo[1,2-a]azepine]-3',5-dione |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]C([H])([H])[C@@]1([H])C(=O)O[C@]2(C1([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N1C(=O)C([H])([H])C([H])([H])[C@@]21[H] |
---|
InChI Identifier | InChI=1S/C13H19NO3/c1-9-8-13(17-12(9)16)6-2-3-7-14-10(13)4-5-11(14)15/h9-10H,2-8H2,1H3/t9-,10+,13+/m1/s1 |
---|
InChI Key | BNTLJWHMOCJBCZ-NRUUGDAUSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
Stemona tuberosa | JEOL database | - Fukaya, H., et al., Chem. Pharm. Bull. 61, 1085 (2013)
|
|
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tuberostemospironine-type alkaloids. These are alkaloids with a structure that is characterized by a 2H-spiro[furan-2,9A[9H]pyrrolo[1,2-a]azepin]-\n5-one nucleus which displays a spiro gamma-lactone at C-9 of the basic ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Stemona alkaloids |
---|
Sub Class | Tuberostemospironine-type alkaloids |
---|
Direct Parent | Tuberostemospironine-type alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Tuberostemospironine backbone
- Pyrroloazepine
- Azepane
- Gamma butyrolactone
- Pyrrolidone
- 2-pyrrolidone
- N-alkylpyrrolidine
- Oxolane
- Pyrrolidine
- Tertiary carboxylic acid amide
- Carboxamide group
- Carboxylic acid ester
- Lactam
- Lactone
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organic oxide
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Guo Z, Bao R, Li Y, Li Y, Zhang J, Tang Y: Tailored Synthesis of Skeletally Diverse Stemona Alkaloids through Chemoselective Dyotropic Rearrangements of beta-Lactones. Angew Chem Int Ed Engl. 2021 Jun 21;60(26):14545-14553. doi: 10.1002/anie.202102614. Epub 2021 May 26. [PubMed:33848039 ]
- Fu J, Shen H, Chang Y, Li C, Gong J, Yang Z: Concise stereoselective synthesis of oxaspirocycles with 1-tosyl-1,2,3-triazoles: application to the total syntheses of (+/-)-Tuberostemospiroline and (+/-)-stemona-lactam R. Chemistry. 2014 Sep 26;20(40):12881-8. doi: 10.1002/chem.201403756. Epub 2014 Aug 21. [PubMed:25145296 ]
- Fukaya H, Hitotsuyanagi Y, Aoyagi Y, Shu Z, Komatsu K, Takeya K: Absolute structures of stemona-lactam S and tuberostemospiroline, alkaloids from stemona tuberosa. Chem Pharm Bull (Tokyo). 2013;61(10):1085-9. doi: 10.1248/cpb.c13-00454. [PubMed:24088701 ]
- Fukaya, H., et al. (2013). Fukaya, H., et al., Chem. Pharm. Bull. 61, 1085 (2013). Chem. Pharm. Bull..
|
---|